Paricalcitol
Oral
Intravenous
Class
Anti-parathyroid hormone agents
Subclass
Vitamin D analogs
Generic name
Paricalcitol
Brand names
Zemplar®
Common formulations
Capsule
Safety risks
Boxed warnings
Seizures
Contraindications
Acute hypercalcemia
Known hypersensitivity to paricalcitol or any of the inactive ingredients
Warnings and precautions
Hypercalcemia
Specific populations
Renal impairment
eGFR 0-90 mL/min/1.73 m²
Renal replacement therapy
Continuous renal replacement
Intermittent hemodialysis
Peritoneal dialysis
Hepatic impairment
Child-Pugh A (mild)
Child-Pugh B (moderate)
Child-Pugh C (severe)
Pregnancy and breastfeeding
Pregnancy
All trimesters • Australia Category: C
Breastfeeding
Little information available on breastfeeding safety.
Unknown amount excreted in breastmilk.
Unknown drug levels in breastfed infants.
Adverse reactions
Very common > 10%
Common 1-10%
Interactions
Drug(s)
Check Interactions
Reset
What did you think about this content?
Sign up for free to access the full drug resource